Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholera | 71 | 2024 | 754 | 7.000 |
Why?
|
Travel | 25 | 2024 | 806 | 4.870 |
Why?
|
Vibrio cholerae | 32 | 2023 | 793 | 3.430 |
Why?
|
Vibrio cholerae O1 | 33 | 2024 | 243 | 3.040 |
Why?
|
Travel Medicine | 10 | 2023 | 83 | 2.160 |
Why?
|
Cholera Vaccines | 20 | 2024 | 264 | 1.830 |
Why?
|
Bangladesh | 52 | 2023 | 745 | 1.530 |
Why?
|
Feces | 13 | 2024 | 1504 | 1.530 |
Why?
|
Vaccination | 26 | 2024 | 3426 | 1.450 |
Why?
|
Antibodies, Bacterial | 36 | 2024 | 1476 | 1.400 |
Why?
|
Rubella | 3 | 2022 | 55 | 1.400 |
Why?
|
Measles-Mumps-Rubella Vaccine | 4 | 2022 | 71 | 1.390 |
Why?
|
Measles | 4 | 2022 | 180 | 1.360 |
Why?
|
Mumps | 3 | 2022 | 70 | 1.350 |
Why?
|
O Antigens | 12 | 2024 | 196 | 1.350 |
Why?
|
Enterobacteriaceae | 4 | 2023 | 161 | 1.350 |
Why?
|
Climate Change | 6 | 2024 | 509 | 1.220 |
Why?
|
Communicable Diseases | 6 | 2024 | 874 | 1.190 |
Why?
|
Diarrhea | 12 | 2024 | 1316 | 1.030 |
Why?
|
Typhoid Fever | 9 | 2023 | 197 | 0.840 |
Why?
|
Drug Resistance, Bacterial | 2 | 2020 | 1069 | 0.820 |
Why?
|
Antigens, Bacterial | 13 | 2019 | 1146 | 0.820 |
Why?
|
Salmonella typhi | 10 | 2023 | 201 | 0.790 |
Why?
|
Immunologic Memory | 14 | 2022 | 1375 | 0.760 |
Why?
|
Vibrio cholerae O139 | 7 | 2023 | 54 | 0.740 |
Why?
|
Colistin | 2 | 2023 | 46 | 0.720 |
Why?
|
Communicable Disease Control | 6 | 2024 | 856 | 0.680 |
Why?
|
Carbapenems | 2 | 2023 | 125 | 0.670 |
Why?
|
Treatment Refusal | 3 | 2017 | 433 | 0.630 |
Why?
|
Immunoglobulin A | 25 | 2024 | 995 | 0.630 |
Why?
|
Cholera Toxin | 18 | 2024 | 563 | 0.590 |
Why?
|
Public Health | 6 | 2023 | 2680 | 0.590 |
Why?
|
Medicine | 2 | 2023 | 942 | 0.580 |
Why?
|
Antibodies, Viral | 9 | 2023 | 3211 | 0.510 |
Why?
|
Specimen Handling | 1 | 2020 | 704 | 0.500 |
Why?
|
Disease Susceptibility | 4 | 2021 | 1789 | 0.500 |
Why?
|
Immunoglobulin G | 30 | 2024 | 4528 | 0.480 |
Why?
|
Disease Outbreaks | 10 | 2020 | 1759 | 0.480 |
Why?
|
Bacterial Proteins | 10 | 2020 | 3837 | 0.470 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2024 | 4058 | 0.460 |
Why?
|
Escherichia coli | 5 | 2023 | 4214 | 0.440 |
Why?
|
Genome, Bacterial | 4 | 2024 | 797 | 0.430 |
Why?
|
Immunoglobulin M | 15 | 2024 | 1528 | 0.420 |
Why?
|
B-Lymphocytes | 13 | 2022 | 4778 | 0.410 |
Why?
|
Yellow Fever | 3 | 2021 | 54 | 0.410 |
Why?
|
Klebsiella Infections | 2 | 2024 | 146 | 0.410 |
Why?
|
Bacteremia | 7 | 2024 | 989 | 0.390 |
Why?
|
Seasons | 2 | 2023 | 1524 | 0.390 |
Why?
|
Health Planning Guidelines | 1 | 2012 | 151 | 0.390 |
Why?
|
Physician's Role | 1 | 2019 | 927 | 0.390 |
Why?
|
beta-Lactamases | 3 | 2023 | 308 | 0.380 |
Why?
|
Humans | 153 | 2024 | 765968 | 0.360 |
Why?
|
Metagenome | 3 | 2023 | 464 | 0.360 |
Why?
|
Lipopolysaccharides | 13 | 2023 | 2216 | 0.350 |
Why?
|
Enterobacteriaceae Infections | 2 | 2023 | 189 | 0.340 |
Why?
|
Family Characteristics | 8 | 2018 | 1001 | 0.340 |
Why?
|
Blood Group Antigens | 3 | 2023 | 183 | 0.330 |
Why?
|
Child, Preschool | 40 | 2024 | 42500 | 0.330 |
Why?
|
Leptospirosis | 2 | 2010 | 45 | 0.320 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.310 |
Why?
|
Dengue | 2 | 2017 | 257 | 0.310 |
Why?
|
Chemoprevention | 3 | 2023 | 327 | 0.300 |
Why?
|
Adolescent | 56 | 2024 | 88835 | 0.300 |
Why?
|
United States | 26 | 2023 | 72903 | 0.300 |
Why?
|
Yellow Fever Vaccine | 2 | 2021 | 38 | 0.280 |
Why?
|
Anti-Bacterial Agents | 12 | 2024 | 7478 | 0.280 |
Why?
|
Young Adult | 45 | 2021 | 59889 | 0.270 |
Why?
|
Child | 47 | 2024 | 80564 | 0.270 |
Why?
|
Serotyping | 3 | 2024 | 330 | 0.270 |
Why?
|
Telemedicine | 1 | 2024 | 3105 | 0.260 |
Why?
|
Antibodies, Neutralizing | 5 | 2022 | 2010 | 0.260 |
Why?
|
Gastrointestinal Tract | 3 | 2024 | 834 | 0.260 |
Why?
|
Mobile Health Units | 2 | 2024 | 91 | 0.260 |
Why?
|
Ambulatory Care Facilities | 2 | 2023 | 939 | 0.260 |
Why?
|
Administration, Oral | 11 | 2021 | 4015 | 0.250 |
Why?
|
Adult | 70 | 2024 | 223044 | 0.250 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 986 | 0.250 |
Why?
|
Klebsiella pneumoniae | 2 | 2024 | 253 | 0.250 |
Why?
|
Temperature | 2 | 2023 | 2226 | 0.240 |
Why?
|
Immunocompromised Host | 2 | 2015 | 866 | 0.230 |
Why?
|
Malaria | 4 | 2017 | 1246 | 0.230 |
Why?
|
Vaccines, Conjugate | 3 | 2015 | 334 | 0.230 |
Why?
|
Antibody-Producing Cells | 3 | 2014 | 138 | 0.230 |
Why?
|
Health Behavior | 2 | 2019 | 2650 | 0.230 |
Why?
|
Immunity, Mucosal | 3 | 2018 | 498 | 0.220 |
Why?
|
Carrier State | 2 | 2020 | 529 | 0.220 |
Why?
|
Hafnia | 1 | 2023 | 3 | 0.220 |
Why?
|
Vaccines, Inactivated | 7 | 2023 | 185 | 0.210 |
Why?
|
Duodenum | 4 | 2018 | 495 | 0.210 |
Why?
|
Female | 71 | 2024 | 396112 | 0.210 |
Why?
|
Microbial Viability | 3 | 2020 | 235 | 0.210 |
Why?
|
Immunity, Innate | 4 | 2019 | 3081 | 0.200 |
Why?
|
Proteome | 2 | 2013 | 1899 | 0.200 |
Why?
|
Metagenomics | 3 | 2023 | 473 | 0.200 |
Why?
|
Knowledge | 1 | 2024 | 178 | 0.200 |
Why?
|
Male | 66 | 2024 | 363698 | 0.200 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2003 | 239 | 0.190 |
Why?
|
Salmonella paratyphi A | 2 | 2013 | 47 | 0.190 |
Why?
|
Paratyphoid Fever | 2 | 2013 | 34 | 0.190 |
Why?
|
Quarantine | 1 | 2024 | 185 | 0.190 |
Why?
|
Weather | 1 | 2023 | 234 | 0.190 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5370 | 0.190 |
Why?
|
Phylogeny | 4 | 2024 | 2832 | 0.190 |
Why?
|
Family Health | 3 | 2018 | 1253 | 0.180 |
Why?
|
Sputum | 1 | 2003 | 513 | 0.180 |
Why?
|
Parasitic Diseases | 1 | 2021 | 76 | 0.180 |
Why?
|
Drug Resistance, Microbial | 1 | 2023 | 833 | 0.170 |
Why?
|
Medically Underserved Area | 1 | 2022 | 266 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 2 | 2013 | 3230 | 0.170 |
Why?
|
Contact Tracing | 2 | 2014 | 274 | 0.170 |
Why?
|
Culture Media | 2 | 2020 | 890 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 4 | 2013 | 18071 | 0.170 |
Why?
|
Microbial Sensitivity Tests | 4 | 2023 | 1971 | 0.170 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 193 | 0.160 |
Why?
|
Infant | 20 | 2022 | 36386 | 0.160 |
Why?
|
Awareness | 1 | 2023 | 653 | 0.160 |
Why?
|
Vaccines | 2 | 2019 | 841 | 0.160 |
Why?
|
Antimalarials | 3 | 2016 | 913 | 0.150 |
Why?
|
Escherichia coli Infections | 2 | 2015 | 519 | 0.150 |
Why?
|
Cyclonic Storms | 1 | 2020 | 121 | 0.150 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2019 | 45 | 0.150 |
Why?
|
Blood | 2 | 2011 | 597 | 0.150 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2019 | 48 | 0.150 |
Why?
|
Meningoencephalitis | 1 | 2019 | 82 | 0.150 |
Why?
|
Immune Evasion | 1 | 2022 | 377 | 0.150 |
Why?
|
Peroxidase | 1 | 2021 | 606 | 0.150 |
Why?
|
Middle Aged | 41 | 2022 | 223009 | 0.140 |
Why?
|
Haiti | 6 | 2017 | 553 | 0.140 |
Why?
|
Environmental Health | 1 | 2020 | 297 | 0.140 |
Why?
|
Americas | 1 | 2017 | 109 | 0.140 |
Why?
|
Lymphocytes | 3 | 2022 | 2599 | 0.140 |
Why?
|
Gene Expression Profiling | 8 | 2018 | 9525 | 0.140 |
Why?
|
Tropical Medicine | 1 | 2017 | 52 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 394 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 670 | 0.140 |
Why?
|
Risk Management | 1 | 2020 | 559 | 0.130 |
Why?
|
RNA, Messenger | 6 | 2023 | 12768 | 0.130 |
Why?
|
Antibody Formation | 4 | 2024 | 1391 | 0.130 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5508 | 0.130 |
Why?
|
Antifungal Agents | 1 | 2022 | 769 | 0.130 |
Why?
|
Fimbriae Proteins | 4 | 2015 | 133 | 0.130 |
Why?
|
Genetic Variation | 2 | 2024 | 6610 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2023 | 778 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2017 | 245 | 0.130 |
Why?
|
Multivariate Analysis | 5 | 2014 | 12056 | 0.120 |
Why?
|
Geography | 1 | 2018 | 652 | 0.120 |
Why?
|
Blood Bactericidal Activity | 5 | 2015 | 123 | 0.120 |
Why?
|
Geographic Information Systems | 1 | 2018 | 280 | 0.120 |
Why?
|
Tetanus Toxin | 1 | 2015 | 46 | 0.120 |
Why?
|
Rivers | 2 | 2013 | 65 | 0.120 |
Why?
|
Fimbriae, Bacterial | 2 | 2005 | 138 | 0.120 |
Why?
|
Public Opinion | 1 | 2019 | 482 | 0.120 |
Why?
|
Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
Japanese Encephalitis Vaccines | 1 | 2014 | 7 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 579 | 0.120 |
Why?
|
Encephalitis Virus, Japanese | 1 | 2014 | 12 | 0.120 |
Why?
|
Encephalitis, Japanese | 1 | 2014 | 13 | 0.120 |
Why?
|
Cross Infection | 1 | 2024 | 1427 | 0.120 |
Why?
|
Convalescence | 1 | 2015 | 107 | 0.120 |
Why?
|
Enterotoxigenic Escherichia coli | 2 | 2015 | 32 | 0.120 |
Why?
|
Genes, Fungal | 2 | 1993 | 441 | 0.110 |
Why?
|
Internationality | 1 | 2020 | 1007 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 26318 | 0.110 |
Why?
|
Interferon-gamma | 2 | 2014 | 3160 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2017 | 2187 | 0.110 |
Why?
|
Leisure Activities | 1 | 2016 | 310 | 0.110 |
Why?
|
Rabies Vaccines | 1 | 2013 | 29 | 0.110 |
Why?
|
Demography | 3 | 2015 | 1641 | 0.110 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2010 | 1141 | 0.110 |
Why?
|
ABO Blood-Group System | 1 | 2016 | 380 | 0.110 |
Why?
|
Mucous Membrane | 2 | 2015 | 657 | 0.110 |
Why?
|
Rabies | 1 | 2013 | 56 | 0.110 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1326 | 0.110 |
Why?
|
Health Education | 1 | 2020 | 1060 | 0.110 |
Why?
|
Endemic Diseases | 1 | 2014 | 189 | 0.110 |
Why?
|
Gene Expression Regulation, Fungal | 2 | 1993 | 494 | 0.100 |
Why?
|
Hydroxymethylbilane Synthase | 1 | 1992 | 6 | 0.100 |
Why?
|
RNA, Bacterial | 2 | 2011 | 392 | 0.100 |
Why?
|
Pregnant Women | 1 | 2017 | 575 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 2 | 2012 | 1811 | 0.100 |
Why?
|
Cohort Studies | 13 | 2022 | 41649 | 0.100 |
Why?
|
Biliary Tract | 1 | 2013 | 137 | 0.100 |
Why?
|
Host-Pathogen Interactions | 3 | 2021 | 1461 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1203 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 813 | 0.100 |
Why?
|
Time Factors | 10 | 2020 | 40065 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1539 | 0.100 |
Why?
|
Intestinal Mucosa | 3 | 2011 | 3046 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5526 | 0.100 |
Why?
|
Bacteria | 2 | 2021 | 2209 | 0.090 |
Why?
|
Inflammasomes | 2 | 2015 | 543 | 0.090 |
Why?
|
Pedigree | 2 | 2009 | 4526 | 0.090 |
Why?
|
Dehydration | 2 | 2010 | 215 | 0.090 |
Why?
|
Pyridoxal Phosphate | 2 | 2001 | 123 | 0.090 |
Why?
|
Pregnancy | 4 | 2023 | 30260 | 0.090 |
Why?
|
Syphilis, Cutaneous | 1 | 2010 | 6 | 0.090 |
Why?
|
Public Health Informatics | 1 | 2011 | 109 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1574 | 0.090 |
Why?
|
Neurosyphilis | 1 | 2010 | 27 | 0.090 |
Why?
|
Aviation | 1 | 2010 | 49 | 0.090 |
Why?
|
Commerce | 1 | 2016 | 611 | 0.090 |
Why?
|
Sanitation | 1 | 2010 | 83 | 0.090 |
Why?
|
Fluid Therapy | 2 | 2012 | 584 | 0.090 |
Why?
|
Zoonoses | 2 | 2024 | 181 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2595 | 0.080 |
Why?
|
Preventive Medicine | 1 | 2011 | 246 | 0.080 |
Why?
|
Oligosaccharides | 1 | 2012 | 406 | 0.080 |
Why?
|
Sepsis | 1 | 2024 | 2606 | 0.080 |
Why?
|
Minisatellite Repeats | 1 | 2010 | 162 | 0.080 |
Why?
|
DNA | 1 | 2023 | 7202 | 0.080 |
Why?
|
Virulence | 4 | 2022 | 1289 | 0.080 |
Why?
|
Water Supply | 1 | 2010 | 204 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1364 | 0.080 |
Why?
|
Public Health Administration | 1 | 2011 | 241 | 0.080 |
Why?
|
Occupational Health | 1 | 2016 | 813 | 0.080 |
Why?
|
Cross Reactions | 2 | 2022 | 824 | 0.080 |
Why?
|
Noise, Occupational | 1 | 2009 | 26 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2418 | 0.080 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.080 |
Why?
|
Fresh Water | 1 | 2008 | 82 | 0.080 |
Why?
|
Selection, Genetic | 1 | 2013 | 878 | 0.080 |
Why?
|
Antibiosis | 1 | 2008 | 46 | 0.080 |
Why?
|
T-Lymphocytes | 4 | 2021 | 10261 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1135 | 0.080 |
Why?
|
Helminthiasis | 1 | 2009 | 81 | 0.070 |
Why?
|
Bacteriophages | 2 | 2008 | 381 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15880 | 0.070 |
Why?
|
Optic Neuritis | 1 | 2010 | 172 | 0.070 |
Why?
|
Fungal Proteins | 1 | 1992 | 899 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 2 | 2014 | 1857 | 0.070 |
Why?
|
Fever | 2 | 2019 | 1603 | 0.070 |
Why?
|
Pandemics | 4 | 2020 | 8703 | 0.070 |
Why?
|
Cytokines | 4 | 2019 | 7421 | 0.070 |
Why?
|
Aged | 16 | 2024 | 171117 | 0.070 |
Why?
|
Proteomics | 4 | 2022 | 3910 | 0.070 |
Why?
|
Bacterial Adhesion | 1 | 2008 | 306 | 0.070 |
Why?
|
Accidents, Occupational | 1 | 2009 | 251 | 0.070 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2009 | 144 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3888 | 0.070 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 348 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1596 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2017 | 3615 | 0.070 |
Why?
|
Risk Factors | 9 | 2023 | 74840 | 0.070 |
Why?
|
Systems Biology | 1 | 2010 | 481 | 0.070 |
Why?
|
Animals | 15 | 2023 | 168764 | 0.070 |
Why?
|
Quinolones | 1 | 2009 | 387 | 0.060 |
Why?
|
Emigrants and Immigrants | 1 | 2012 | 549 | 0.060 |
Why?
|
Communication | 1 | 2020 | 3916 | 0.060 |
Why?
|
Computer Simulation | 2 | 2018 | 6255 | 0.060 |
Why?
|
Th17 Cells | 3 | 2022 | 786 | 0.060 |
Why?
|
Epitopes | 2 | 2022 | 2523 | 0.060 |
Why?
|
Counseling | 3 | 2022 | 1551 | 0.060 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2009 | 592 | 0.060 |
Why?
|
Saccharomyces cerevisiae | 2 | 1993 | 2674 | 0.060 |
Why?
|
Disease Models, Animal | 6 | 2015 | 18293 | 0.060 |
Why?
|
Insect Bites and Stings | 2 | 2018 | 71 | 0.060 |
Why?
|
Risk Assessment | 7 | 2018 | 24282 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2485 | 0.060 |
Why?
|
Climatic Processes | 1 | 2024 | 3 | 0.060 |
Why?
|
Antibody Specificity | 2 | 2021 | 1061 | 0.060 |
Why?
|
Disease Vectors | 1 | 2024 | 61 | 0.060 |
Why?
|
Fossil Fuels | 1 | 2024 | 53 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2009 | 1997 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3965 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9249 | 0.050 |
Why?
|
Boston | 2 | 2020 | 9338 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2009 | 1555 | 0.050 |
Why?
|
Family | 2 | 2015 | 3209 | 0.050 |
Why?
|
Immunization | 3 | 2015 | 1219 | 0.050 |
Why?
|
Mice | 11 | 2022 | 81819 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3807 | 0.050 |
Why?
|
Signal Transduction | 2 | 2018 | 23601 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4588 | 0.050 |
Why?
|
Pneumocystis carinii | 1 | 2003 | 70 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Intestine, Small | 2 | 2007 | 1214 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2016 | 59489 | 0.050 |
Why?
|
Prospective Studies | 5 | 2023 | 54802 | 0.050 |
Why?
|
Haplotypes | 1 | 2009 | 2728 | 0.050 |
Why?
|
Neuraminidase | 1 | 2022 | 190 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4405 | 0.050 |
Why?
|
Viral Load | 2 | 2022 | 3386 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1142 | 0.050 |
Why?
|
Immunization Schedule | 1 | 2023 | 228 | 0.050 |
Why?
|
Multigene Family | 1 | 2005 | 1080 | 0.050 |
Why?
|
Disease Transmission, Infectious | 1 | 2007 | 560 | 0.050 |
Why?
|
Histidinol | 1 | 2001 | 1 | 0.050 |
Why?
|
Pakistan | 1 | 2023 | 300 | 0.050 |
Why?
|
beta-Lactams | 1 | 2023 | 158 | 0.050 |
Why?
|
Gene Frequency | 1 | 2009 | 3624 | 0.050 |
Why?
|
Virulence Factors | 1 | 2005 | 500 | 0.050 |
Why?
|
Genotype | 3 | 2015 | 13024 | 0.050 |
Why?
|
Th1 Cells | 3 | 2012 | 1039 | 0.050 |
Why?
|
Azithromycin | 1 | 2023 | 201 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7875 | 0.050 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1889 | 0.050 |
Why?
|
Th2 Cells | 3 | 2012 | 1075 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 404 | 0.050 |
Why?
|
Agglutination | 1 | 2020 | 42 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4736 | 0.050 |
Why?
|
Microbial Interactions | 1 | 2021 | 74 | 0.050 |
Why?
|
Drug Design | 1 | 2006 | 1042 | 0.050 |
Why?
|
Animals, Suckling | 1 | 2020 | 69 | 0.050 |
Why?
|
Internship and Residency | 1 | 2021 | 5946 | 0.040 |
Why?
|
Atlantic Ocean | 1 | 2020 | 24 | 0.040 |
Why?
|
Mycoses | 1 | 2024 | 389 | 0.040 |
Why?
|
Urban Population | 2 | 2010 | 2040 | 0.040 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17594 | 0.040 |
Why?
|
Transaminases | 1 | 2001 | 199 | 0.040 |
Why?
|
Occupational Diseases | 1 | 2009 | 1456 | 0.040 |
Why?
|
School Health Services | 1 | 2024 | 387 | 0.040 |
Why?
|
Health Surveys | 1 | 2010 | 4056 | 0.040 |
Why?
|
Immunization, Secondary | 2 | 2014 | 373 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13266 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2022 | 1947 | 0.040 |
Why?
|
Erythromycin | 2 | 2010 | 114 | 0.040 |
Why?
|
Disasters | 1 | 2006 | 520 | 0.040 |
Why?
|
Plasmids | 2 | 2017 | 2274 | 0.040 |
Why?
|
Health Personnel | 1 | 2014 | 3390 | 0.040 |
Why?
|
Genomics | 3 | 2024 | 5929 | 0.040 |
Why?
|
Acetyltransferases | 1 | 2001 | 229 | 0.040 |
Why?
|
Odds Ratio | 2 | 2009 | 9649 | 0.040 |
Why?
|
Colony Count, Microbial | 2 | 2012 | 326 | 0.040 |
Why?
|
Public Policy | 1 | 2024 | 551 | 0.040 |
Why?
|
Tetracycline | 2 | 2010 | 216 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 428 | 0.040 |
Why?
|
Accidents, Traffic | 2 | 2018 | 818 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3685 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 621 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 907 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4772 | 0.040 |
Why?
|
Endotoxins | 1 | 2021 | 516 | 0.040 |
Why?
|
Occupational Exposure | 1 | 2009 | 1805 | 0.040 |
Why?
|
Community Health Centers | 1 | 2022 | 469 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2022 | 995 | 0.040 |
Why?
|
Barotrauma | 1 | 2018 | 40 | 0.040 |
Why?
|
Developing Countries | 1 | 2010 | 2911 | 0.040 |
Why?
|
Food Safety | 1 | 2018 | 24 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1015 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2024 | 26346 | 0.040 |
Why?
|
Ships | 1 | 2018 | 53 | 0.040 |
Why?
|
Phosphates | 1 | 2001 | 763 | 0.040 |
Why?
|
Alleles | 1 | 2009 | 6897 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 645 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2019 | 22223 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5786 | 0.040 |
Why?
|
Proteins | 2 | 2011 | 5995 | 0.040 |
Why?
|
Models, Molecular | 3 | 2022 | 5379 | 0.040 |
Why?
|
Biofilms | 1 | 2022 | 641 | 0.030 |
Why?
|
Administration, Cutaneous | 2 | 2012 | 715 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4618 | 0.030 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 148 | 0.030 |
Why?
|
Altitude Sickness | 1 | 2018 | 93 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2022 | 718 | 0.030 |
Why?
|
Aircraft | 1 | 2018 | 135 | 0.030 |
Why?
|
Amino Acid Sequence | 4 | 2001 | 13400 | 0.030 |
Why?
|
Asia | 1 | 2018 | 628 | 0.030 |
Why?
|
Intestines | 1 | 2005 | 1906 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15652 | 0.030 |
Why?
|
HIV | 1 | 2003 | 1585 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 721 | 0.030 |
Why?
|
Synteny | 1 | 2015 | 76 | 0.030 |
Why?
|
Africa | 1 | 2018 | 725 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14751 | 0.030 |
Why?
|
Age Distribution | 2 | 2014 | 2858 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 164 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1207 | 0.030 |
Why?
|
Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.030 |
Why?
|
Vitamin A | 2 | 2008 | 610 | 0.030 |
Why?
|
Molecular Typing | 1 | 2015 | 115 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1016 | 0.030 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2015 | 58 | 0.030 |
Why?
|
Virus Diseases | 1 | 2021 | 718 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2341 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2009 | 4544 | 0.030 |
Why?
|
Biopsy | 2 | 2018 | 6763 | 0.030 |
Why?
|
Calgranulin A | 1 | 2015 | 80 | 0.030 |
Why?
|
Zinc | 2 | 2008 | 675 | 0.030 |
Why?
|
Peer Review, Research | 1 | 2017 | 341 | 0.030 |
Why?
|
Databases, Factual | 1 | 2009 | 8067 | 0.030 |
Why?
|
Uroporphyrinogen Decarboxylase | 1 | 1993 | 4 | 0.030 |
Why?
|
Bacterial Load | 1 | 2014 | 156 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6069 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 791 | 0.030 |
Why?
|
Africa, Western | 1 | 2013 | 160 | 0.030 |
Why?
|
Yellow fever virus | 1 | 2013 | 23 | 0.030 |
Why?
|
Rectum | 2 | 2009 | 896 | 0.030 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2013 | 126 | 0.030 |
Why?
|
Prophages | 1 | 2013 | 39 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2717 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3620 | 0.030 |
Why?
|
Antibodies | 1 | 2021 | 2417 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2017 | 696 | 0.030 |
Why?
|
Hot Temperature | 1 | 2019 | 1433 | 0.030 |
Why?
|
Liver Glycogen | 1 | 1992 | 36 | 0.030 |
Why?
|
Protein Binding | 2 | 2022 | 9296 | 0.030 |
Why?
|
Dominican Republic | 1 | 2012 | 78 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1620 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3797 | 0.030 |
Why?
|
Sphingolipids | 1 | 1994 | 178 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 586 | 0.020 |
Why?
|
Point Mutation | 1 | 2017 | 1590 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6220 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 81514 | 0.020 |
Why?
|
Environmental Illness | 1 | 2012 | 33 | 0.020 |
Why?
|
Nepal | 1 | 2013 | 301 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2024 | 3564 | 0.020 |
Why?
|
Education, Medical | 1 | 2024 | 1746 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2013 | 399 | 0.020 |
Why?
|
Antitoxins | 1 | 2012 | 75 | 0.020 |
Why?
|
Brain | 1 | 2019 | 27171 | 0.020 |
Why?
|
Altruism | 1 | 2014 | 211 | 0.020 |
Why?
|
Friends | 1 | 2013 | 151 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2018 | 667 | 0.020 |
Why?
|
Health Policy | 1 | 2024 | 2698 | 0.020 |
Why?
|
Animals, Newborn | 2 | 2008 | 2669 | 0.020 |
Why?
|
Occupations | 1 | 2013 | 516 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 586 | 0.020 |
Why?
|
Paneth Cells | 1 | 2011 | 99 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5881 | 0.020 |
Why?
|
Rehydration Solutions | 1 | 2010 | 44 | 0.020 |
Why?
|
Headache | 1 | 2019 | 1259 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 312 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1992 | 1546 | 0.020 |
Why?
|
Syphilis Serodiagnosis | 1 | 2010 | 37 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 3655 | 0.020 |
Why?
|
Treponema pallidum | 1 | 2010 | 48 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 682 | 0.020 |
Why?
|
Caribbean Region | 1 | 2010 | 193 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 1993 | 4165 | 0.020 |
Why?
|
Enterotoxins | 1 | 2012 | 366 | 0.020 |
Why?
|
Publishing | 1 | 2017 | 835 | 0.020 |
Why?
|
DNA Topoisomerase IV | 1 | 2009 | 42 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12976 | 0.020 |
Why?
|
Nigeria | 1 | 2013 | 782 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2024 | 5343 | 0.020 |
Why?
|
Brain Diseases | 1 | 2019 | 1546 | 0.020 |
Why?
|
Dimerization | 2 | 2001 | 880 | 0.020 |
Why?
|
Bacterial Typing Techniques | 1 | 2010 | 263 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2011 | 291 | 0.020 |
Why?
|
Space Flight | 1 | 1992 | 219 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2006 | 7851 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11888 | 0.020 |
Why?
|
Scotoma | 1 | 2010 | 128 | 0.020 |
Why?
|
Latin America | 1 | 2010 | 416 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8733 | 0.020 |
Why?
|
DNA Gyrase | 1 | 2009 | 86 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2010 | 521 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8875 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2010 | 276 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3776 | 0.020 |
Why?
|
Quebec | 1 | 2009 | 140 | 0.020 |
Why?
|
Guillain-Barre Syndrome | 1 | 2010 | 128 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2587 | 0.020 |
Why?
|
Bacterial Translocation | 1 | 2008 | 74 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1992 | 792 | 0.020 |
Why?
|
Chromosomes, Bacterial | 1 | 2009 | 281 | 0.020 |
Why?
|
Doxycycline | 1 | 2010 | 349 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1993 | 1167 | 0.020 |
Why?
|
Spectrophotometry, Atomic | 1 | 2008 | 80 | 0.020 |
Why?
|
Serum | 1 | 2009 | 206 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 17533 | 0.020 |
Why?
|
Mutagenesis | 1 | 1992 | 1228 | 0.020 |
Why?
|
Epidemics | 1 | 2014 | 514 | 0.020 |
Why?
|
Protein Structure, Secondary | 2 | 2001 | 1210 | 0.020 |
Why?
|
Malnutrition | 1 | 2014 | 629 | 0.020 |
Why?
|
Microbiological Techniques | 1 | 2008 | 96 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 752 | 0.020 |
Why?
|
Ciprofloxacin | 1 | 2009 | 314 | 0.020 |
Why?
|
Bacteriolysis | 1 | 2007 | 51 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1984 | 0.020 |
Why?
|
Autoantigens | 1 | 2011 | 883 | 0.020 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 400 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 1993 | 3737 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14652 | 0.020 |
Why?
|
Incidence | 3 | 2011 | 21480 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 18973 | 0.020 |
Why?
|
Biological Evolution | 1 | 2012 | 1072 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 995 | 0.020 |
Why?
|
Blindness | 1 | 2010 | 586 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2012 | 924 | 0.020 |
Why?
|
Mutation | 3 | 2022 | 30198 | 0.020 |
Why?
|
Migraine Disorders | 1 | 2019 | 1732 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5446 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2229 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2009 | 765 | 0.020 |
Why?
|
Exanthema | 1 | 2010 | 502 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1477 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 2406 | 0.010 |
Why?
|
Escherichia coli Proteins | 1 | 2012 | 1057 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2511 | 0.010 |
Why?
|
Age Factors | 2 | 2012 | 18380 | 0.010 |
Why?
|
Base Sequence | 2 | 1993 | 12403 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15398 | 0.010 |
Why?
|
World Health Organization | 1 | 2010 | 1328 | 0.010 |
Why?
|
Military Personnel | 1 | 2013 | 1252 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 1526 | 0.010 |
Why?
|
Mucins | 1 | 2007 | 567 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6493 | 0.010 |
Why?
|
Acute Disease | 1 | 2015 | 7232 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2243 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1992 | 1892 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12437 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4562 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2721 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20124 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2194 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2263 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1770 | 0.010 |
Why?
|
Immunoassay | 1 | 2006 | 741 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22332 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4850 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1383 | 0.010 |
Why?
|
Binding Sites | 2 | 2001 | 6001 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4209 | 0.010 |
Why?
|
Microscopy | 1 | 2007 | 901 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2741 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2334 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3458 | 0.010 |
Why?
|
Keto Acids | 1 | 2001 | 32 | 0.010 |
Why?
|
Amino Acids | 2 | 2001 | 1709 | 0.010 |
Why?
|
Protein Structure, Quaternary | 1 | 2001 | 423 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2014 | 4642 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29922 | 0.010 |
Why?
|
Spectrum Analysis | 1 | 2001 | 443 | 0.010 |
Why?
|
Catalysis | 1 | 2001 | 770 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10070 | 0.010 |
Why?
|
Health Status | 1 | 2012 | 4080 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5089 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9514 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 1430 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65188 | 0.010 |
Why?
|
Poverty | 1 | 2010 | 2714 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11022 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4331 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2171 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 1752 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7425 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2745 | 0.010 |
Why?
|
Skin | 1 | 2010 | 4489 | 0.010 |
Why?
|
Liver | 1 | 1992 | 7562 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9591 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10429 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10808 | 0.010 |
Why?
|
Digestion | 1 | 1994 | 53 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3750 | 0.010 |
Why?
|
Tritium | 1 | 1994 | 702 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9443 | 0.010 |
Why?
|
Intestinal Absorption | 1 | 1994 | 399 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1994 | 543 | 0.010 |
Why?
|
Ceramides | 1 | 1994 | 201 | 0.010 |
Why?
|
RNA, Fungal | 1 | 1993 | 156 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1993 | 572 | 0.010 |
Why?
|
Sphingosine | 1 | 1994 | 306 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36532 | 0.010 |
Why?
|
Mixed Function Oxygenases | 1 | 1992 | 265 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2077 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1994 | 602 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39193 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1994 | 2266 | 0.010 |
Why?
|
Aging | 1 | 2008 | 8731 | 0.010 |
Why?
|
Colon | 1 | 1994 | 1795 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23707 | 0.000 |
Why?
|